Novartis AG (NVS)

Last Closing Price: 115.92 (2025-08-07)

Cash Flow from Financial Activities (Quarterly)

Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.

Novartis AG (NVS) had Cash Flow from Financial Activities of $-13.76B for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$14.84B
$4.04B
$3.32B
$11.51B
$9.97B
$4.86B
$-333.00M
$4.53B
$4.53B
$4.02B
$4.02B
$4.02B
$4.02B
$4.86B
$4.86B
1.95B
1.96B
$2.07
$2.06
Balance Sheet Financials
$25.94B
$10.38B
$78.46B
$104.39B
$31.71B
$22.47B
$30.63B
$62.34B
$42.05B
$-12.74B
$42.05B
1.94B
Cash Flow Statement Financials
$10.31B
$-1.91B
Cash Flow from Financial Activities
$-13.76B
$11.46B
$6.66B
$-4.80B
--
$-7.82B
--
Fundamental Metrics & Ratios
0.82
--
--
0.35
0.73
77.61%
32.79%
32.79%
--
30.54%
27.24%
$9.73B
--
--
--
0.14
0.53
1.62
55.66
9.57%
-31.59%
3.85%
6.24%
$21.72
$4.97
$5.26